Commonwealth Equity Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,512
| Closed | -$833K | – | 3881 |
|
|
2022
Q3 | $833K | Sell |
5,512
-259
| -4% | -$39.1K | ﹤0.01% | 2033 |
|
|
2022
Q2 | $840K | Sell |
5,771
-482
| -8% | -$70.2K | ﹤0.01% | 2038 |
|
|
2022
Q1 | $741K | Buy |
6,253
+397
| +7% | +$47K | ﹤0.01% | 2219 |
|
|
2021
Q4 | $807K | Buy |
5,856
+989
| +20% | +$136K | ﹤0.01% | 2145 |
|
|
2021
Q3 | $676K | Sell |
4,867
-133
| -3% | -$18.5K | ﹤0.01% | 2245 |
|
|
2021
Q2 | $485K | Buy |
5,000
+574
| +13% | +$55.7K | ﹤0.01% | 2497 |
|
|
2021
Q1 | $302K | Sell |
4,426
-36
| -0.8% | -$2.46K | ﹤0.01% | 2757 |
|
|
2020
Q4 | $382K | Sell |
4,462
-245
| -5% | -$21K | ﹤0.01% | 2355 |
|
|
2020
Q3 | $306K | Buy |
4,707
+188
| +4% | +$12.2K | ﹤0.01% | 2344 |
|
|
2020
Q2 | $330K | Buy |
+4,519
| New | +$330K | ﹤0.01% | 2207 |
|